The cellular response to oxygen deprivation-hypoxic response-is essential for cell proliferation and survival. The hypoxia-inducible transcription factor, HIF-1α, apparently acts as a master regulator of oxygen homeostasis by virtue of its critical role in regulating an array of hypoxia-responsive genes. [1] [2] [3] [4] [5] [6] [7] [8] [9] HIF-1α is known to upregulate hypoxia-inducible genes such as EPO, VEGF and PGK1 through dimerization with ARNT (also known as HIF-1β), 10 recruitment of the transcription coactivator p300/CBP, [11] [12] [13] and binding to the hypoxia-responsive element in the promoter. 14 Furthermore, our previous study demonstrated that HIF-1α also utilizes a novel HIF-1α-Myc mechanism to activate CDKN1A (also known as p21 cip1 ) expression, involving functional antagonism of the transcription repressor Myc via protein-protein interactions. 15 Remarkably, this alternative mechanism is independent of HIF-1α DNA binding and transcriptional activity; instead, HIF-1α displaces Myc from binding to the CDKN1A promoter, resulting in gene activation. 15 It is noteworthy that cells not only upregulate genes in adaptation to oxygen deprivation, but downregulate hypoxia-responsive genes to complement the cellular event, both of which merit equal amount of attention for a comprehensive understanding of the hypoxic response. 16 We have shown recently that the HIF-1α-Myc mechanism also accounts for hypoxic downregulation of MSH2 and MSH6, 17 whose protein products constitute MutSα, a MSH2-MSH6 heterodimer that is crucial for DNA mismatch repair. [18] [19] [20] The fate of the hypoxia-responsive genes in this category seems to be determined by the intrinsic function of Myc that controls transcription. In stark contrast to its repression of CDKN1A, Myc activates MSH2 expression. 21 Hence, the HIF-1α antagonism of Myc results in MSH2 downregulation. 17 Intriguingly, neither HIF-1α nor Myc binds directly to the MSH2 promoter. Rather, both HIF-1α and Myc discretely interacts with the constitutively bound transcription factor Sp1 on the MSH2 promoter, whereas HIF-1α dominates Sp1 binding in hypoxia by competing against Myc. As a result, Sp1 acts as a molecular switch by recruiting HIF-1α for the hypoxic repression of MSH2. The identification of Sp1 in the HIF-1α-Myc pathway may provide a framework for the further understanding of how other hypoxia-responsive genes are downregulated by hypoxia.
A salient point of this study is the requirement of the tumor suppressor p53 for the hypoxic downregulation of MSH2 and MSH6. Either deletion or knockdown of TP53 reduced basal expression of MSH2 and MSH6, resulting in a loss of further inhibition by hypoxia. Conversely, introduction of TP53 into TP53-null cells recapitulated the MSH2 and MSH6 inhibition by hypoxia. However, no such regulation was seen in p53-inactivated cells. Although the p53 core domain has been reported recently to bind the HIF-1α ODD domain, 22 the latter is not required for HIF-1α repression of MSH2 and MSH6 expression. Thus, the mechanism by which p53 engages in repressing hypoxiaresponsive genes remains obscure.
The human DNA mismatch repair system plays a crucial role in safeguarding the genomic integrity by correcting DNA replication errors and by blocking recombination events between divergent DNA sequences. 18, 23 Mutations in the mismatch repair genes are associated with the development of both hereditary and sporadic cancers, and germline mutations in MSH2 or MLH1 are the most prevalent cause of hereditary nonpolyposis colorectal cancers. 20 To demonstrate the intricate relationships among p53, HIF-1α, and MSH2 in vivo, we examined the gene expression patterns with immunohistochemistry in nonhereditary human colon cancers. Stratified results based on the p53 status manifest a striking inverse correlation between HIF-1α and MSH2 in the p53-undetectable group harboring wild-type p53 (Fig. 1) . However, no such correlation exists in the p53-detectable group harboring p53 mutants. Therefore, these results substantiate the role of HIF-1α in suppressing MSH2 expression in the presence of wild-type p53.
A highly relevant question about these findings is how the reduction of MutSα levels by HIF-1α relates to the cellular adaptation to hypoxia. To that end, we have proposed that balancing the supply and demand of theintracellular ATP is key to this adaptive response. In essence, not only does HIF-1α maintain intracellular ATP production by stimulating angiogenesis and glycolysis, but also reduces ATP consumption by inhibiting cell proliferation and DNA repair. This theory apparently explains why cell populations under hypoxic stress experience multifaceted consequences, including gene mutation and cell death, in addition to cell survival. These adverse events are seemingly an inevitable price associated with the survival of cell populations under hypoxic stress. Accordingly, during tumor development hypoxic microenvironment is created in the name of cell survival, at the expense of gene mutation, and even of cell death. Figure 1 . An inverse correlation of HIF-1α and MSH2 expression in p53 stratified nonhereditary colon cancers. The immunohistochemistry results from a total of 80 specimens (Unstratified) and from p53 stratified groups (p53-undetectable and p53-detectable) were plotted in axes, labeled with the number of cases, MSH2, and HIF-1α, respectively. The plus sign indicates positive staining, and the minus sign negative staining. The green column depicts specimens stained positive for MSH2 but negative for HIF-1α, whereas the red denotes the reverse. Likewise, the orange column represents both MSH2 and HIF-1α positive, and the grey means both negative.
